Clinical Trials for Blasts More Than 5 Percent of Bone Marrow Nucleated Cells

Find clinical trials for blasts more than 5 percent of bone marrow nucleated cells. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT ID: NCT03896269

This clinical trial is looking at a new treatment called CPX-351 for patients with high-risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) that has either returned after ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

NCT ID: NCT04049539

This clinical trial is studying a treatment called Vyxeos for patients with a type of blood cancer called acute myeloid leukemia (AML) who still have disease after their initial chemotherapy. Vyxeo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Sacramento, California, United States

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT ID: NCT03801434

This clinical trial is studying a medication called ruxolitinib to see how well it works for patients with hypereosinophilic syndrome or other related blood disorders. These conditions are characte...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, Portland, Oregon, United States +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions